Helus Pharma Inc (HELP): Next-Year EPS Estimate 27.67%
As of 2026-06-29, Helus Pharma Inc (HELP) has a next-year EPS growth estimate of 27.67%. Featured in 3 EPS revision reports, most recently on 2026-06-30.
On 2026-06-21, analyst consensus for HELP's next-year EPS growth shifted from 25.44% to 27.67% — a positive change of 2.23 percentage points. The revised estimate has been sustained across 7 subsequent trading sessions. Current-year growth is projected at 0.82%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 27.67%
- EPS growth this year
- 0.82%
- EPS next quarter (est)
- -$0.82
- Last price
- $6.88
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-29 | 27.67% | 0.82% | -$0.82 | $6.88 |
| 2026-06-28 | 27.67% | 0.82% | -$0.82 | $6.48 |
| 2026-06-25 | 27.67% | 0.82% | -$0.82 | $6.02 |
| 2026-06-24 | 27.67% | 0.82% | -$0.82 | $5.09 |
| 2026-06-23 | 27.67% | 0.82% | -$0.82 | $4.85 |
| 2026-06-22 | 27.67% | 0.82% | -$0.82 | $4.85 |
| 2026-06-21 | 27.67% | 0.82% | -$0.82 | $4.67 |
| 2026-04-13 | 25.44% | 1.47% | -$0.79 | $5.24 |
| 2026-04-12 | 25.44% | 1.47% | -$0.79 | $5.22 |
| 2026-04-10 | 25.44% | 1.47% | -$0.79 | $5.25 |
| 2026-04-09 | 25.44% | 1.47% | -$0.79 | $5.24 |
| 2026-04-08 | 25.44% | N/A | -$0.79 | $5.25 |
| 2026-04-07 | 25.44% | N/A | -$0.79 | $5.25 |
| 2026-04-06 | 25.44% | N/A | -$0.79 | $5.25 |
| 2026-04-05 | 25.44% | N/A | -$0.79 | $5.12 |
| 2026-04-03 | 25.44% | N/A | -$0.79 | $5.25 |
| 2026-04-02 | 25.44% | N/A | -$0.79 | $5.25 |
| 2026-04-01 | 25.44% | N/A | -$0.79 | $5.25 |
| 2026-04-01 | 25.44% | N/A | N/A | $4.99 |
| 2026-04-01 | 25.44% | N/A | N/A | $4.99 |
| 2026-04-01 | 25.44% | N/A | N/A | $4.99 |
| 2026-03-31 | 25.44% | N/A | N/A | $4.80 |
| 2026-03-31 | 25.44% | N/A | N/A | $4.80 |
| 2026-03-31 | 25.44% | N/A | N/A | $4.80 |
| 2026-03-30 | 25.44% | N/A | N/A | $4.32 |
| 2026-03-30 | 25.44% | N/A | N/A | $4.32 |
| 2026-03-30 | 25.44% | N/A | N/A | $4.32 |
| 2026-03-29 | 25.44% | N/A | N/A | $4.52 |
| 2026-03-29 | 25.44% | N/A | N/A | $4.52 |
| 2026-03-27 | 25.44% | N/A | N/A | $4.52 |
Reports Featuring HELP
Screen Performance
Aggregate stats across all 2130 tickers our top-EPS-revision screen has flagged over the past 219 days.
- Median return since detection
- -3.9%
- % of tickers in the green
- 41%
- Median return on winners
- +23.3%
- Large revisions captured
- 2083
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Helus Pharma Inc's next-year EPS growth estimate?▾
As of 2026-06-29, Helus Pharma Inc (HELP) has a next-year EPS growth estimate of 27.67%, based on analyst consensus.
When was the latest EPS estimate revision for HELP?▾
The most recent revision occurred on 2026-06-21, when analysts adjusted the next-year EPS growth estimate from 25.44% to 27.67%.
What sector and industry does Helus Pharma Inc belong to?▾
Helus Pharma Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. HELP appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Helus Pharma Inc (HELP) appears here because it was detected by our daily top-EPS-revision-performer screen.